Related by context. All words. (Click for frequent words.) 82 genotypes 74 allele 72 alleles 70 polymorphism 69 homozygous 69 heterozygous 69 phenotype 68 polymorphisms 68 HCV genotype 67 genotypic 67 haplotype 66 genotyped 66 Genotype 66 subtype 65 homozygotes 65 SNPs 64 CC genotype 64 heterozygotes 64 mutation 64 genetic variant 63 genetic variants 63 seronegative 63 haplotypes 63 genetic variation 63 DRD2 62 allele frequencies 62 NNRTI resistance 62 EGFR mutations 62 gene variant 62 homozygosity 62 phenotypes 61 rs# [001] 61 IL#B 61 rs# [003] 61 rs# [002] 61 homozygote 61 HBV genotype 61 rs# [004] 61 HLA DRB1 * 61 gene variants 61 HCV genotypes 61 gene 61 HTLV 61 UGT#A# * 61 mutant allele 61 genetic polymorphisms 61 HCV infected 60 VKORC1 60 orthologs 60 genetic markers 60 loci 60 haplogroups 60 hepatitis C genotype 60 K#N 60 haplogroup 60 subtypes 60 genetic variations 60 mRNA expression 60 TT genotype 60 apolipoprotein E gene 59 mutations 59 penetrance 59 IGFBP 59 genetic variability 59 ABCB1 59 MetS 59 PTPN# 59 G allele 59 C#Y 59 genes 59 gene polymorphism 59 OPRM1 gene 59 APOE4 59 seropositivity 59 5 HTTLPR 59 GABRA2 59 MTHFR 58 HLA B 58 single nucleotide polymorphism 58 APOE gene 58 coinfection 58 APOE e4 58 MHC genes 58 HCV genotype 1 58 KRAS gene 58 ApoE 58 KRAS mutations 58 phenotypic 58 genotypic resistance 58 allelic 58 missense mutations 58 sporadic ALS 58 diploid 58 SLC#A# [002] 58 gene mutations 58 Genotypes 58 intron 58 NRTI resistance 58 PCa 58 serum concentrations 58 VNTR 58 indels 58 K ras 57 GSTM1 57 CFH gene 57 K#R [002] 57 CYP#C# * 57 heterozygote 57 dopamine receptor gene 57 APOE genotype 57 germline mutations 57 allele frequency 57 ADH1B * 57 A. thaliana 57 microsatellite markers 57 gene locus 57 ALDH2 57 BRCA mutations 57 virologic failure 57 T2DM 57 linkage disequilibrium 57 C#BL/#J 57 genomes 57 HPV# 57 heterozygosity 57 APOE 57 virological response 57 cagA 57 CCR5 tropic HIV 57 colorectal neoplasia 57 HBeAg 57 CYP#D# 57 CNVs 57 K ras mutations 57 allelic variants 57 MYH9 gene 57 transfected 57 gene mutation 57 haptoglobin 57 TIMP 57 FMR1 gene 57 receptor gene 57 DQB1 * 57 homologs 57 virologic response 57 HLA DRB1 57 Genetic variation 57 MC1R gene 57 KRAS mutation 57 mtDNA 57 APOE ε4 57 estrogen receptor ER 56 gene expression patterns 56 P. falciparum 56 #q# [001] 56 neutralizing antibody 56 GSTT1 56 CagA 56 Haplogroup 56 nondiabetic 56 coinfected 56 missense mutation 56 transgene expression 56 ERBB2 56 variant allele 56 FTO variant 56 HLA B# 56 DRD4 56 mutated gene 56 M#V mutation 56 microsatellite instability 56 serotype 56 HBeAg positive 56 proband 56 BRCA mutation 56 transgene 56 activin 56 human leukocyte antigen 56 MLH1 56 functional polymorphism 56 IgA deficiency 56 HBeAg negative 56 diabetes mellitus DM 56 prostate cancer CaP 56 phenotypically 56 breast carcinomas 56 heritable traits 56 major histocompatibility complex 56 HLA DQ2 56 genes encoding 56 EGFR mutation 56 viremia 56 CCL#L# 56 nucleotide sequence 56 autoantibody 56 autosomal 56 KLF4 56 QTLs 56 gene expression 56 C#BL 6 mice 56 serogroup 56 CYP#C# [001] 56 quantitative trait loci 56 SNP rs# [001] 56 CDKN2A 56 APOC3 56 chromosomal regions 56 Her2/neu 56 epithelial ovarian cancer 56 MRSA isolates 56 mutant alleles 56 inhibin 56 MnSOD 56 #q# [002] 55 2 diabetes T2D 55 variant alleles 55 GSTP1 55 genetic variants associated 55 HBeAg negative chronic hepatitis 55 susceptibility genes 55 karyotype 55 HBsAg 55 gene expression profiles 55 univariate analysis 55 CYP#D# genotype 55 karyotypes 55 HNSCC 55 dopamine transporter gene 55 CYP#C# [002] 55 CpG 55 methylation patterns 55 Anopheles gambiae 55 isoform 55 T2D 55 ApoE4 55 promoter methylation 55 del 5q 55 LRAT 55 hereditary hemochromatosis 55 clade B 55 BRAF mutation 55 HIV RNA 55 MTHFR gene 55 FLT3 55 apolipoproteins 55 telomere lengths 55 EBV infection 55 isoforms 55 HLA DR2 55 Haptoglobin 55 genetic polymorphism 55 euthyroid 55 ADRB2 55 adiponectin concentrations 55 ELISPOT 55 ortholog 55 seroprevalence 55 syngeneic 55 exomes 55 mosaicism 55 subfamily 55 HIV HCV coinfected 55 M. bovis 55 HCV 55 APOE allele 55 exon 55 chromosome #q# [002] 55 elevated triglyceride levels 55 frameshift mutation 55 miRNAs 55 clusterin 55 K ras gene 55 MAOA 55 genomewide 55 LPA gene 55 PON1 55 mutated K ras 55 coinfected patients 55 #S rRNA 55 genes CYP#C# 55 miRNA expression 55 epitope 55 phenotypic variation 55 variant rs# 55 gastric carcinogenesis 55 adenoma 55 CHEK2 55 A1 allele 55 HIV uninfected 55 chromosome #p# [001] 55 alternatively spliced 55 paternally inherited 55 aldehyde dehydrogenase 55 gene loci 55 HCV infection 55 APOL1 55 IgM 55 TACI mutations 55 PTEN mutations 55 cystatin 55 ESR1 55 CDH1 54 IFN gamma 54 BRCA2 mutation 54 CYP#D# gene 54 ERCC1 54 antibody titer 54 herpesviruses 54 antibody responses 54 pseudogenes 54 isoenzyme 54 apolipoprotein E 54 logistic regression analysis 54 catechol O methyltransferase 54 microdeletions 54 viral load 54 Plasmodium falciparum 54 univariate analyzes 54 clades 54 essential thrombocythemia 54 apolipoprotein 54 Apolipoprotein E 54 gene polymorphisms 54 CISH 54 genetically 54 UGT#A# 54 NAFLD 54 Haplotype 54 LTBI 54 genetic loci 54 Supplementary Table 54 ApoE gene 54 C#BL 6 54 JAK2 V#F 54 tropism 54 microalbuminuria 54 differential gene expression 54 DENV 54 SLC#A# [001] 54 RASSF1A 54 breast carcinoma 54 virulence genes 54 prognostic marker 54 multivariate analyzes 54 C. albicans 54 methylenetetrahydrofolate reductase 54 genetic makeup 54 genome 54 FGFR2 54 differentially expressed genes 54 metabolic syndrome 54 APOE e4 gene 54 liver transplant recipients 54 unmutated 54 μmol L 54 genetic mutation 54 heritable 54 DRD4 gene 54 H pylori 54 CCR5 delta# 54 miR #a [001] 54 CAG repeats 54 KIF6 gene 54 CYP#C# gene 54 mutant gene 54 clonal 54 allelic variation 54 comorbidity 54 HLA molecules 54 Apolipoprotein 54 chlamydial infection 54 COL#A# 54 gestational diabetes mellitus 54 CEACAM1 54 Serotype 54 DRD2 gene 54 antibody titers 54 HER2 expression 54 NAT2 54 poor metabolizers 54 conditional logistic regression 54 HLA DRB1 SE 54 noncarriers 54 claudin 54 MGUS 54 IgG antibody 54 immunodeficient 54 posaconazole 54 HCV SPRINT 53 BRCA1 mutations 53 serological 53 intergenic 53 nucleotide substitutions 53 mCRC patients 53 genotype 1a 53 subpopulations 53 serologic 53 macroalbuminuria 53 TOP2A 53 tertile 53 coding sequences 53 metastatic RCC 53 HFE gene 53 HLA alleles 53 virologic 53 C. trachomatis 53 HLA genes 53 chromosome #q 53 downregulated 53 germline mutation 53 mitochondrial DNA mtDNA 53 genes predisposing 53 M. genitalium 53 sequence homology 53 FDG uptake 53 vivax 53 serum vitamin D 53 MHC molecules 53 valine 53 subcellular localization 53 TIMP 1 53 uPAR 53 genotyping 53 MMSE score 53 logistic regression 53 MAOA gene 53 spontaneous mutation 53 null mice 53 KRAS wild 53 PALB2 53 phenotypic traits 53 logistic regression models 53 PTEN gene 53 LQTS 53 isoprostane 53 TCF#L# gene 53 clade 53 mg kg dose 53 Immunohistochemical analysis 53 causal variants 53 mitochondrial genome 53 HBV genotypes 53 Genotypic 53 cyclin E 53 synteny 53 WNK1 53 TMEM#B 53 gastric adenocarcinoma 53 Hepatitis B virus 53 isoenzymes 53 virologic responses 53 alanine aminotransferase ALT 53 apoA 53 susceptibility gene 53 H. pylori 53 colorectal tumors 53 #S rRNA genes 53 H#K#me# 53 lymphocytosis 53 seropositive 53 aneuploid 53 telomere length 53 serum HBV DNA 53 activating mutations 53 transgenic mice 53 univariate 53 biochemical recurrence 53 Logistic regression 53 serotonin transporter 53 CDK4 53 cDNA 53 cDNA libraries 53 HCV replicon 53 prognostic factor 53 gene sequences 53 esophageal squamous cell carcinoma 53 immunostaining 53 enfuvirtide 53 Lymphocyte 53 microcephalin 53 HepG2 cells 53 titers 53 BRAF V#E mutation 53 genomic 53 % CI #.#-#.# [006] 53 log# copies mL 53 mRNA transcripts 53 GSTM1 gene 53 μg ml 53 IDH1 mutation 53 epistasis 53 MEK1 53 ADPKD 53 Heterozygous 53 ε4 53 logistic regression model 53 polygenic 53 amino acid substitutions 53 cardioprotective effects 53 db db mice 53 peripheral blood mononuclear 53 lymphoblastoid cell lines 53 BVDV 53 gefitinib 53 HBeAg negative patients 53 nucleotide substitution 53 overexpression 53 STAT4 53 Leydig cell 53 sustained virologic response 53 rheumatoid factor 53 C. neoformans 53 CYP# [002] 53 bacterial genomes 53 Supplemental Figure 53 SSc 53 lactase persistence 53 fasting glucose levels 53 constitutively active 52 S. cerevisiae 52 underlying pathophysiology 52 outcrossing 52 platelet reactivity 52 elevated CRP 52 NY ESO 52 BARD1 52 multivariate analysis 52 FMR1 52 HER2/neu 52 promoter polymorphism 52 immunocompetent 52 HLA DR4 immune 52 n = 52 antitumor effect 52 K RAS 52 HT 2A 52 Multivariate analysis 52 PIK3CA 52 fig. S1 52 genetic ancestry 52 diabetes mellitus 52 PBMCs 52 tHcy 52 Phylogenetic analysis 52 idiopathic myelofibrosis 52 autosomal dominant 52 ZNF# 52 parasitaemia 52 chromosome #q# [001] 52 confidence interval #.#-#.# 52 plasma folate 52 immunological 52 TLR3 52 Gag polymorphisms 52 thyroglobulin 52 OPRM1 52 tyrosine phosphorylation 52 5alpha reductase 52 α KG 52 perilipin 52 AUDs 52 EGFR gene 52 NNRTI resistant virus 52 S. enterica 52 multivariable analysis 52 gene encoding 52 BDNF gene 52 SNP rs# [002] 52 immunoglobulin genes 52 T#I [002] 52 defensin 52 normotensive 52 IKZF1 52 genetic 52 autosomes 52 gambiae 52 DRB1 * 52 missense 52 subclinical hypothyroidism 52 sCJD 52 ASCUS 52 mitochondrial gene 52 Neuregulin 1 52 hepatoma 52 amino acid substitution 52 HBV 52 MSH2 52 COMT 52 prospectively randomized 52 TP# mutation 52 chronic HCV genotype 52 pneumoniae 52 #p# [001] 52 inbred strains 52 KRAS status 52 IL#R 52 genetic determinants 52 familial ALS 52 TCF#L# 52 V#F mutation 52 transcriptome 52 virological failure 52 prognostic factors 52 superinfection 52 LRRK2 gene 52 NHANES III 52 poorer prognosis 52 narcolepsy cataplexy 52 immunohistochemistry 52 chronic HBV infection 52 prion protein gene 52 BRAF V#E 52 prostate cancer PCa 52 gene amplification 52 chromosomal alterations 52 TGFBR1 * 6A 52 plasma glucose 52 lamivudine resistant 52 IgG antibodies 52 EGFR mutation status 52 autosomal dominant disorder 52 HLA DR4 52 cytochrome b 52 dinucleotide 52 tumor subtypes 52 somatic mutations 52 HMGA2 52 darunavir ritonavir 52 #p# [003] 52 substrate specificity 52 biotype 52 serum PTH 52 COMT gene 52 microarray experiments 52 hepatic fibrosis 52 HRCT 52 P. patens 52 viral tropism 52 asymptomatic 52 clinicopathological 52 mice lacking 52 Wwox 52 ADH1B 52 pDCs 52 nephropathy 52 granulocyte 52 drug metabolizing enzymes 52 viral kinetics 52 serovar 52 thymosin 52 enzymatic activity 52 immunoreactivity 52 PFGE 52 BRCA1 52 prospective cohort 52 nucleotide 52 BCG vaccinated 52 SE alleles 52 nmol L 52 sCD# 52 caveolin 52 2n = 52 chlorambucil 52 qRT PCR 52 serum selenium 52 rhesus 52 RRM1 52 mtDNA mutations 52 estrogen receptor 52 receptor binding 52 Supplementary Fig 52 hydroxylase 52 CNTNAP2 52 undetectable HBV DNA 52 HbF levels 52 multivariate logistic regression 52 causative gene 52 gallstone disease 52 probands 52 Subtype 52 BRCA1 mutation 52 phospholipase 52 pharmacokinetics PK 52 rituximab monotherapy 52 oral glucose tolerance 52 pg ml 52 transduced 52 activating mutation 52 neutralizing antibody responses 52 binding affinity 52 protease inhibitor PI 52 airway hyperresponsiveness 52 herpes simplex virus 52 autoantibodies 52 lymph node metastasis 52 thrombospondin 52 microdeletion 52 ALDH 52 Kruskal Wallis test 52 hydroxyvitamin D levels 52 genomic DNA 52 HNPCC 52 pCR 52 chromosome 52 tumor histology 52 histone modification 52 apoE4 52 viral strains 52 intestinal biopsy 52 orthologous 52 rhGH 52 orthologous genes 52 IPAH 52 HER2 overexpression 52 Hp2 2 52 serotonin transporter gene 52 lamivudine 52 constitutively 52 ANOVA 52 #q#.# [001] 52 NRTIs 52 HBV DNA 52 Bacteroides 52 IDH2 52 basal cell nevus syndrome 52 normal karyotype 52 diabetes mellitus T2DM 51 circulating IGF 51 serum albumin 51 subclinical 51 chronic HCV infection 51 M. leprae 51 HLA 51 HOMA IR 51 S#A# [002] 51 upregulated 51 HIV1 51 CD8 + 51 phenotypic characteristics 51 genomic alterations 51 lactis 51 transcriptional repressor 51 Subgroup analyzes 51 receptor kinase 51 lymphocyte 51 Trichomonas vaginalis 51 ovarian carcinoma 51 Clusterin 51 H. influenzae 51 etiologic agent 51 brucei 51 interferon IFN 51 CCR7 51 cytokeratin 51 myostatin gene 51 TOMM# 51 ß = 51 methylation 51 chromosome #q#.# [001] 51 CCR5 mutation 51 selfing 51 wildtype 51 bulimia nervosa 51 C. jejuni 51 breast cancer subtypes 51 EGFRvIII 51 liver histology 51 covariates 51 transgenic rats 51 NPM1 mutations 51 D2 receptors 51 Polymorphism 51 multigene 51 IFN α 51 fluoroquinolone resistance 51 cytopathic 51 EGFP 51 BMP2 51 indel 51 lipid abnormalities 51 serum BDNF 51 dizygotic 51 D. melanogaster 51 IL# [001] 51 microRNA expression 51 fluoroquinolone resistant 51 Plasmodium 51 atypical hyperplasia 51 virus HBV 51 peginterferon 51 heterologous expression 51 aminotransferase 51 NF1 51 alpha synuclein gene 51 folate deficiency 51 Polymorphisms 51 clonally 51 HIV coinfected 51 resistant isolates 51 adalimumab 51 urocortin 51 inhibitory receptor 51 prognostically 51 deleterious mutation 51 GH IGF 51 chronically infected 51 triacylglycerol 51 HCMV 51 pathogenic mutations 51 IFN alpha 51 glycated hemoglobin levels 51 transmembrane protein 51 C1q 51 apoE 51 hepatocellular carcinomas 51 -#.# ± [002] 51 allogeneic SCT 51 MEFs 51 causative mutation 51 colorectal carcinoma 51 clade C 51 caspofungin 51 paralogs 51 flavopiridol 51 K ras mutation 51 malignant nodules 51 CGG repeats 51 TPMT 51 heavily pretreated 51 homodimers 51 Saccharomyces cerevisiae 51 Lactobacillus 51 systemic lupus erythematosus 51 monozygotic twins 51 HSCT 51 murine 51 PUFA intake 51 CD4 + CD# 51 ApoE4 gene 51 cytogenetic abnormalities 51 FCGR3A 51 epigenetic mechanisms 51 alpha2 51 nanomolar 51 triglyceride levels 51 neoplastic 51 psychiatric comorbidity 51 atopic 51 gonadotropins 51 MC1R 51 tipranavir ritonavir 51 receiving VICTRELIS 51 EGFR 51 alcohol dehydrogenase 51 impaired glucose tolerance 51 CIN2 + 51 prevalences 51 mammographic density 51 subpopulation 51 Arabidopsis genome 51 IGFBP 3 51 genetic mutations 51 neoadjuvant chemotherapy 51 histologic 51 multidrug resistance 51 antiviral activity 51 single nucleotide polymorphisms 51 monozygotic 51 transgenes 51 synuclein 51 NNRTIs 51 neuroD2 51 BRCA 51 lymphocytic 51 serum IGF 51 quasispecies 51 maternally inherited 51 glycosylation 51 UCP2 51 HPV subtypes 51 nelfinavir 51 mitochondrial genomes 51 unmethylated 51 BRCA1 mutation carriers 51 Mycobacterium tuberculosis 51 stage IIIB 51 #S rRNA gene 51 prospectively defined 51 mitochondrial 51 albumin excretion 51 cell adhesion molecule 51 HER2 amplification 51 mammary gland tumors 51 CSF biomarkers 51 ribosomal proteins 51 dietary intakes 51 P. falciparum parasites 51 hnRNP 51 immunologically 51 CD4 + CD8 + 51 heritability 51 DMARD 51 papillary RCC 51 mutational 51 phylogenetic analysis 51 coronary calcification 51 albicans 51 glucocorticoid 51 N Myc 51 KIT mutations 51 glycemia 51 hepatocellular carcinoma HCC 51 CETP gene 51 Foxp3 51 C. pneumoniae 51 NRTI 51 leukocyte count 51 sustained virological response 51 MECP2 gene 51 IL#B gene 51 viral loads 51 survivin 51 serum leptin 51 parainfluenza virus 51 prognostic significance 51 prodynorphin 51 breast cancer genes BRCA1 51 T1D 51 ß1 51 depressive symptoms 51 CLL cells 51 malignant lymphoma 51 aneuploidy 51 autosomal recessive 51 kinase domain 51 c KIT 51 posttransplant 51 abnormal cytology 51 ApoB 51 basal cell carcinoma BCC 51 colorectal tumor 51 glycoproteins 51 viremic 51 overexpressing 51 HMGA1 51 β thalassemia 51 apolipoprotein E4 51 isomerase 51 prognostic indicator 51 hsCRP levels 51 ascending doses 51 DAT1 51 Sjögren syndrome 51 hepatocellular carcinoma 51 haematopoietic 51 tumor subtype 51 downregulation 51 GG genotype 51 NF1 gene 51 independent prognostic marker 51 microbiota 51 HLA DR 51 WT1 51 nonalcoholic steatohepatitis NASH 51 serum samples 50 HER-2/neu 50 E. faecalis 50 chronic lymphocytic leukemia CLL 50 serotonin receptor 50 evolutionarily conserved 50 taxane therapy 50 mutant BRAF 50 BCL#A 50 GNAQ 50 UGT#B# 50 eotaxin 50 circadian clock genes 50 albuminuria 50 S. Typhimurium 50 GBM tumors 50 amino acid sequence 50 dizygotic twins 50 atherogenic dyslipidemia 50 antigen 50 CXCR4 50 Alleles 50 inducible nitric oxide synthase 50 seroprotection 50 multivariate Cox 50 e antigen HBeAg 50 pDC 50 heterodimers 50 chlamydial 50 Cytogenetic 50 NPY gene 50 TP# mutations 50 hepatitis C virus 50 proto oncogene 50 comorbidities